Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 178

Sort by

Sort Order Select

Journal Articles

Diagnostic workflow for hereditary erythrocytosis and thrombocytosis

Mary Frances McMullin

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 391–396.

https://doi.org/10.1182/hematology.2019000047

Published: 2019

Journal Articles

Minimal residual disease and stem cell transplantation outcomes

Jacqueline Cloos, Gert J. Ossenkoppele, Richard Dillon

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 617–625.

https://doi.org/10.1182/hematology.2019000006

Published: 2019

Journal Articles

The growing landscape of FLT3 inhibition in AML

Catherine C. Smith

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 539–547.

https://doi.org/10.1182/hematology.2019000058

Published: 2019

Journal Articles

Single-agent and combination biologics in acute myeloid leukemia

Guillaume Richard-Carpentier, Courtney D. DiNardo

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 548–556.

https://doi.org/10.1182/hematology.2019000059

Published: 2019

Journal Articles

In MDS, is higher risk higher reward?

Guillermo F. Sanz

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 381–390.

https://doi.org/10.1182/hematology.2019000042

Published: 2019

Journal Articles

MRD evaluation of AML in clinical practice: are we there yet?

Sylvie D. Freeman, Christopher S. Hourigan

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 557–569.

https://doi.org/10.1182/hematology.2019000060

Published: 2019

Journal Articles

Molecular profiling and management of mantle cell lymphoma

Jia Ruan

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 30–40.

https://doi.org/10.1182/hematology.2019000011

Published: 2019

Journal Articles

Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome

Jibran Durrani, Jaroslaw P. Maciejewski

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 97–104.

https://doi.org/10.1182/hematology.2019000019

Published: 2019

Journal Articles

Clonal dynamics in chronic lymphocytic leukemia

Catherine Gutierrez, Catherine J. Wu

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 466–475.

https://doi.org/10.1182/hematology.2019000367

Published: 2019

Journal Articles

Monitoring and treatment of MDS in genetically susceptible persons

Stella M. Davies

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 105–109.

https://doi.org/10.1182/hematology.2019000020

Published: 2019

Journal Articles

Selecting Frontline Therapy for CLL in 2018

Nitin Jain

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 242–247.

https://doi.org/10.1182/asheducation-2018.1.242

Published: 2018

Journal Articles

JAK2 (and other genes) be nimble with MPN diagnosis, prognosis, and therapy

Michele Ciboddo, Ann Mullally

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 110–117.

https://doi.org/10.1182/asheducation-2018.1.110

Published: 2018

Journal Articles

Genomics of aggressive B-cell lymphoma

Allison Rosenthal, Lisa Rimsza

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 69–74.

https://doi.org/10.1182/asheducation-2018.1.69

Published: 2018

Journal Articles

The MDS genomics-prognosis symbiosis

Aziz Nazha

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 270–276.

https://doi.org/10.1182/asheducation-2018.1.270

Published: 2018

Journal Articles

Treatments targeting MDS genetics: a fool’s errand?

Amy E. DeZern

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 277–285.

https://doi.org/10.1182/asheducation-2018.1.277

Published: 2018

Journal Articles

Using genomics to define pediatric blood cancers and inform practice

Rachel E. Rau, Mignon L. Loh

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 286–300.

https://doi.org/10.1182/asheducation-2018.1.286

Published: 2018

Journal Articles

Clinical consequences of clonal hematopoiesis of indeterminate potential

David P. Steensma

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 264–269.

https://doi.org/10.1182/asheducation-2018.1.264

Published: 2018

Journal Articles

Challenges and implications of genomics for T-cell lymphomas

Eric D. Jacobsen, David M. Weinstock

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 63–68.

https://doi.org/10.1182/asheducation-2018.1.63

Published: 2018

Journal Articles

When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter

Gregory W. Roloff, Elizabeth A. Griffiths

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 35–44.

https://doi.org/10.1182/asheducation-2018.1.35

Published: 2018

Journal Articles

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

Daria V. Babushok

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 457–466.

https://doi.org/10.1182/asheducation-2018.1.457

Published: 2018

NARROW

Diagnostic workflow for hereditary erythrocytosis and thrombocytosis

Minimal residual disease and stem cell transplantation outcomes

The growing landscape of FLT3 inhibition in AML

Single-agent and combination biologics in acute myeloid leukemia

In MDS, is higher risk higher reward?

MRD evaluation of AML in clinical practice: are we there yet?

Molecular profiling and management of mantle cell lymphoma

Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome

Clonal dynamics in chronic lymphocytic leukemia

Monitoring and treatment of MDS in genetically susceptible persons

Selecting Frontline Therapy for CLL in 2018

JAK2 (and other genes) be nimble with MPN diagnosis, prognosis, and therapy

Genomics of aggressive B-cell lymphoma

The MDS genomics-prognosis symbiosis

Treatments targeting MDS genetics: a fool’s errand?

Using genomics to define pediatric blood cancers and inform practice

Clinical consequences of clonal hematopoiesis of indeterminate potential

Challenges and implications of genomics for T-cell lymphomas

When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only